Search

everythinglearnresearchcommunity

for

Search:↓

Decreased CD200 in hair follicles may cause immune issues in some alopecia areata cases.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Topical tacrolimus did not regrow hair in alopecia universalis patients.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

A rare genetic mutation found in an Indian family can be detected through prenatal screening.

New treatments for enlarged prostate are being developed to be more effective and have fewer side effects.

Dihydrotestosterone treatment can help penis growth in boys with 5α-reductase deficiency but doesn't fully normalize size after puberty.

Hair follicles are smaller in people with androgenetic alopecia compared to those with normal scalps.

Proper skin toxicity management in chemotherapy is key to continuing treatment and keeping patient quality of life high.

New techniques have enhanced our understanding of how stem cells function and the role of mutations in aging tissues, which may influence future cancer therapies.

A substance called Vascular Endothelial Growth Factor can protect certain hair follicle stem cells from damage caused by androgens, suggesting a new possible treatment for hair loss.

Some acne medications have side effects; doctors should educate patients and may not need to do frequent lab tests for all.

NEMO syndrome and systemic lupus erythematosus are linked in a new disease association.

After menopause, some women lose scalp hair and gain facial hair, with patterns suggesting different underlying causes.

N-acetyl-L-cysteine (NAC) can prevent DNA damage and protect cells from harm.

AI is effective in diagnosing and treating hair disorders, including detecting hair loss and scalp conditions with high accuracy, but it should supplement, not replace, doctor-patient interactions.

Diagnosing alopecia areata is challenging and requires careful examination and various tests to distinguish it from other hair loss types.

Innovative methods are reducing animal testing and improving biomedical research.

The review emphasizes the need to recognize skin conditions that affect hair follicles and sweat glands to avoid misdiagnosis.

In June 2019, the stem cell research field saw major progress, including new clinical trials, FDA approvals, and industry collaborations.

Cicatricial alopecia, a permanent hair loss condition, is mainly caused by damage to specific hair follicle stem cells and abnormal immune responses, with gene regulator PPAR-y and lipid metabolism disorders playing significant roles.

IL6 is linked to higher risk of heart disease in people with a certain mouth condition.

Diabetes can cause a variety of skin disorders, some of which may signal more serious health issues.

The document concludes that treating skin conditions should include psychological care and a multidisciplinary approach is essential for effective management.

Minoxidil treats hair loss, promotes growth, has side effects, and has recent patents.

Dextran sulfate was found to be toxic and ineffective for treating HIV.

Formyl-peptide receptor agonists could be new anti-inflammatory drugs.

Products should be called 'sperm-safe' only after thorough, well-designed tests.

Scarring alopecia affects different hair follicle stem cells than nonscarring alopecia, and the infundibular region could be a new treatment target.

Minoxidil's effectiveness decreases as vehicle evaporates; concentration and thermodynamic activity matter.